Early-stage splenic diffuse large B-cell lymphoma is highly associated with hepatitis C virus infection

Kaohsiung Journal of Medical Sciences

Volumn 29, Issue 3, 2013, Pages 150-156

  Yu, Shan Chi ^a   Lin, Chung Wu ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Diffuse large B cell lymphoma; Hepatitis C virus; Lymphoma; Spleen; Splenic marginal zone lymphoma

Indexed keywords

ADULT; ARTICLE; CANCER STAGING; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; JAPAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; PATHOGENESIS; SEROLOGY; SEROPREVALENCE; SPLENIC MARGINAL ZONE LYMPHOMA; UNIVERSITY HOSPITAL;

FEMALE; HEPATITIS C; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; NEOPLASM STAGING; SEROEPIDEMIOLOGIC STUDIES; SPLEEN; SPLENIC NEOPLASMS; TAIWAN;

EID: 84875251884     PISSN: 1607551X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.kjms.2012.08.025     Document Type: Article

References (30)

1. D.L. Ahmann, J.M. Kiely, E.G. Harrison Jr., and W.S. Payne Malignant lymphoma of the spleen. A review of 49 cases in which the diagnosis was made at splenectomy Cancer 19 1966 461 469
2. D.A. Arber, H. Rappaport, and L.M. Weiss Non-Hodgkin's lymphoproliferative disorders involving the spleen Mod Pathol 10 1997 18 32
3. M. Mollejo, J. Menarguez, E. Lloret, A. Sanchez, E. Campo, and P. Algara Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases Am J Surg Pathol 19 1995 1146 1157
4. J. Kang, J.H. Cho, C.W. Suh, D.H. Lee, H.B. Oh, and Y.H. Sohn High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignancies Ann Hematol 90 2011 159 164
5. R. Talamini, M. Montella, M. Crovatto, L. Dal Maso, A. Crispo, and E. Negri Non-Hodgkin's lymphoma and hepatitis C virus: a case-control study from northern and southern Italy Int J Cancer 110 2004 380 385
6. S.S. Chuang, Y.L. Liao, S.T. Chang, Y.C. Hsieh, S.Y. Kuo, and C.L. Lu Hepatitis C virus infection is significantly associated with malignant lymphoma in Taiwan, particularly with nodal and splenic marginal zone lymphomas J Clin Pathol 63 2010 595 598
7. V. Ascoli, F. Lo Coco, M. Artini, M. Levrero, M. Martelli, and F. Negro Extranodal lymphomas associated with hepatitis C virus infection Am J Clin Pathol 109 1998 600 609
8. L. Arcaini, M. Paulli, E. Boveri, D. Vallisa, P. Bernuzzi, and E. Orlandi Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles Cancer 100 2004 107 115
9. M. Takeshita, H. Sakai, S. Okamura, Y. Oshiro, K. Higaki, and O. Nakashima Splenic large B-cell lymphoma in patients with hepatitis C virus infection Hum Pathol 36 2005 878 885
10. P.G. Gobbi, G.E. Grignani, U. Pozzetti, D. Bertoloni, C. Pieresca, and G. Montagna Primary splenic lymphoma: does it exist? Haematologica 79 1994 286 293
11. G.L. Armstrong, A. Wasley, E.P. Simard, G.M. McQuillan, W.L. Kuhnert, and M.J. Alter The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 Ann Intern Med 144 2006 705 714
12. M. Cornberg, H.A. Razavi, A. Alberti, E. Bernasconi, M. Buti, and C. Cooper A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel Liver Int 31 Suppl. 2 2011 30 60
13. W. Sievert, I. Altraif, H.A. Razavi, A. Abdo, E.A. Ahmed, and A. Alomair A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt Liver Int 31 Suppl. 2 2011 61 80
14. M.H. Lee, H.I. Yang, C.L. Jen, S.N. Lu, S.H. Yeh, and C.J. Liu Community and personal risk factors for hepatitis C virus infection: a survey of 23,820 residents in Taiwan in 1991-2 Gut 60 2011 688 694
15. C.H. Chen, P.M. Yang, G.T. Huang, H.S. Lee, J.L. Sung, and J.C. Sheu Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants J Formos Med Assoc 106 2007 148 155
16. A. Mele, A. Pulsoni, E. Bianco, P. Musto, A. Szklo, and M.G. Sanpaolo Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study Blood 102 2003 996 999
17. E.A. Engels, N. Chatterjee, J.R. Cerhan, S. Davis, W. Cozen, and R.K. Severson Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study Int J Cancer 111 2004 76 80
18. M. Takeshita, H. Sakai, S. Okamura, K. Higaki, Y. Oshiro, and N. Uike Prevalence of hepatitis C virus infection in cases of B-cell lymphoma in Japan Histopathology 48 2006 189 198
19. A. De Renzo, F. Perna, M. Persico, R. Notaro, C. Mainolfi, and I. de Sio Excellent prognosis and prevalence of HCV infection of primary hepatic and splenic non-Hodgkin's lymphoma Eur J Haematol 81 2008 51 57
20. M. Ivanovski, F. Silvestri, G. Pozzato, S. Anand, C. Mazzaro, and O.R. Burrone Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas Blood 91 1998 2433 2442
21. D. Rosa, G. Saletti, E. De Gregorio, F. Zorat, C. Comar, and U. D'Oro Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders Proc Natl Acad Sci USA 102 2005 18544 18549
22. Z. Chen, Y. Zhu, Y. Ren, Y. Tong, X. Hua, and F. Zhu Hepatitis C virus protects human B lymphocytes from Fas-mediated apoptosis via E2-CD81 engagement PLoS One 6 2011 e18933
23. K. Machida, K.T. Cheng, N. Pavio, V.M. Sung, and M.M. Lai Hepatitis C virus E2-CD81 interaction induces hypermutation of the immunoglobulin gene in B cells J Virol 79 2005 8079 8089
24. G. Morsica, G. Tambussi, G. Sitia, R. Novati, A. Lazzarin, and L. Lopalco Replication of hepatitis C virus in B lymphocytes (CD19+) Blood 94 1999 1138 1139
25. V.M. Sung, S. Shimodaira, A.L. Doughty, G.R. Picchio, H. Can, and T.S. Yen Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection J Virol 77 2003 2134 2146
26. A. Alisi, C. Giannini, A. Spaziani, S. Anticoli, P. Caini, and A.L. Zignego Hepatitis C virus core protein enhances B lymphocyte proliferation Dig Liver Dis 39 Suppl. 1 2007 S72 S75
27. B.D. Cheson, S.J. Horning, B. Coiffier, M.A. Shipp, R.I. Fisher, and J.M. Connors Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group J Clin Oncol 17 1999 1244 1253
28. M.P. Curry, L. Golden-Mason, D.G. Doherty, T. Deignan, S. Norris, and M. Duffy Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver J Hepatol 38 2003 642 650
29. E. Zuckerman, G. Slobodin, A. Kessel, E. Sabo, D. Yeshurun, and K. Halas Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection Clin Exp Immunol 128 2002 353 358
30. O. Hermine, F. Lefrere, J.P. Bronowicki, X. Mariette, K. Jondeau, and V. Eclache-Saudreau Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection N Engl J Med 347 2002 89 94